Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.
Affluent Medical develops innovative new-generation mini-invasive implants to restore essential physiological functions in these areas: - Kardiozis aims to prevent endoleaks and risks of recurrence of the abdominal aortic aneurysm allowing patients to live more serenely facing an unpredictable risk of breakage; - Kalios and Epygon aim to provide more physiological surgical treatments for the repair or replacement of the mitral valve of the heart. Kalios can treat residual post-operative leakage and recurrent mitral insufficiency without having to reoperate patients. Epygon is today the only developing transcatheter valve to restore natural blood flow and safeguard the left ventricle. - Finally, Artus is the first electronically activatable artificial sphincter to treat stress urinary incontinence in men and women.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 14, 2018 | Debt Financing | €12M | 1 | Kreos Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kreos Capital | Yes | Debt Financing |